The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance
Open accessAbstract
The development of malignant disease might be seen as a failure of immune surveillance. However, not all tumors are naturally immunogenic, and even among those that are immunogenic, the uncontrolled rapid growth of a tumor may sometimes out-run a robust immune response. Nevertheless, recent evidence suggests that mechanisms of tolerance that normally exist to prevent autoimmune disease may also preclude the development of an adequate antitumor response and that tumors themselves have the ability to thwart the development of effective immune responses against their antigens. A major challenge has been to develop approaches to breaking this tolerance in tumor-bearing hosts, and recent advances in our understanding of antigen presentation and tolerance have led to some promising strategies. An alternative approach is to use T cells from nontumor-bearing, allogeneic hosts in the form of lymphocyte infusions, with or without hematopoietic cell transplantation. Immunotherapy may occur in this setting via the response of nontolerant, tumor antigen-specific T cells from nontumor-bearing hosts or via the powerful destructive effect of an alloresponse directed against antigens shared by malignant cells in the recipient. Approaches to exploiting this beneficial effect without the deleterious consequence of graft-versus-host disease in allogeneic hematopoietic cell recipients are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Graft-versus-leukemia reactions after bone marrow transplantation
Horowitz, M., Gale, R., Sondel, P., Goldman, J., Kersey, J., Kolb, H., Rimm, A., Ringden, O., Rozman, C., & Speck, B. (1990) · Blood · doi:10.1182/blood.v75.3.555.555 · Cited by 2,774
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
T cell tolerance by clonal elimination in the thymus
Kappler, J. W., Roehm, N., & Marrack, P. (1987) · Cell · doi:10.1016/0092-8674(87)90568-x · Cited by 2,211
Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., et al. (1998) · Blood · doi:10.1182/blood.v91.3.756 · Cited by 2,071
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Eshhar, Z., Waks, T., Gross, G., & Schindler, D. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.720 · Cited by 1,658
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
Kolb, H., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M., & Wilmanns, W. (1990) · Blood · doi:10.1182/blood.v76.12.2462.2462 · Cited by 1,528
Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
Weiden, P. L., Flournoy, N., Thomas, E. D., Prentice, R., Fefer, A., Buckner, C. D., & Storb, R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905103001902 · Cited by 1,510
Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J., & Emerson, S. G. (1999) · Science · doi:10.1126/science.285.5426.412 · Cited by 1,186
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
Steinman, R. M., & Nussenzweig, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231606698 · Cited by 1,166
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., et al. (1997) · Blood · doi:10.1182/blood.v89.12.4531 · Cited by 1,138
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
Townsend, S. E., & Allison, J. P. (1993) · Science · doi:10.1126/science.7678351 · Cited by 1,136
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R., Thomas, E. D., & The Seattle Marrow Transplant Team (1981) · New England Journal of Medicine · doi:10.1056/nejm198106183042507 · Cited by 1,081
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
T-cell apoptosis detected in situ during positive and negative selection in the thymus
Surh, C. D., & Sprent, J. (1994) · Nature · doi:10.1038/372100a0 · Cited by 1,066
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301703 · Cited by 1,043
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Rosenberg, S. A., Yannelli, J. R., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Parkinson, D. R., Seipp, C. A., Einhorn, J. H., & White, D. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.15.1159 · Cited by 1,019
Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009143431101 · Cited by 998
Khouri, I. F., Keating, M., Körbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., von Wolff, B., Gajewski, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2817 · Cited by 919
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
Differential Requirements for Survival and Proliferation of CD8 Naïve or Memory T Cells
Tanchot, C., Lemonnier, F. A., Pérarnau, B., Freitas, A. A., & Rocha, B. (1997) · Science · doi:10.1126/science.276.5321.2057 · Cited by 856
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Gorelik, L., & Flavell, R. A. (2001) · Nature Medicine · doi:10.1038/nm1001-1118 · Cited by 770
Mackinnon, S., Papadopoulos, E., Carabasi, M., Reich, L., Collins, N., Boulad, F., Castro-Malaspina, H., Childs, B., Gillio, A., & Kernan, N. (1995) · Blood · doi:10.1182/blood.v86.4.1261.bloodjournal8641261 · Cited by 722
Ernst, B., Lee, D.-S., Chang, J. M., Sprent, J., & Surh, C. D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80092-8 · Cited by 717
Hill, G. R., & Ferrara, J. L. M. (2000) · Blood · doi:10.1182/blood.v95.9.2754.009k25_2754_2759 · Cited by 715
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Spectrum of AIDS-associated malignant disorders
Goedert, J. J., Coté, T. R., Virgo, P., Scoppa, S. M., Kingma, D. W., Gail, M. H., Jaffe, E. S., & Biggar, R. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09028-4 · Cited by 701
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
Stockert, E., Jäger, E., Chen, Y.-T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., & Old, L. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1349 · Cited by 698
Woo, E. Y., Yeh, H., Chu, C. S., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., & June, C. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4272 · Cited by 696
Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E., & Davis, M. M. (2000) · Nature Medicine · doi:10.1038/79526 · Cited by 672
Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H., & Ohtani, H. (2001) · PubMed · Cited by 639
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., & Ochoa, A. C. (1992) · Science · doi:10.1126/science.1465616 · Cited by 632
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, F., Vossen, J., Gratwohl, A., Vogelsang, G. B., van Houwelingen, H. C., & van Rood, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340501 · Cited by 605
Jaffee, E. M., Hruban, R. H., Biedrzycki, B., Laheru, D., Schepers, K., Sauter, P. R., Goemann, M., Coleman, J., Grochow, L., Donehower, R. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.145 · Cited by 600
Bendandi, M., Gocke, C. D., Kobrin, C. B., Benko, F. A., Sternas, L. A., Pennington, R., Watson, T. M., Reynolds, C. W., Gause, B. L., Duffey, P. L., et al. (1999) · Nature Medicine · doi:10.1038/13928 · Cited by 594
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
Gong, J., Chen, D., Kashiwaba, M., & Kufe, D. (1997) · Nature Medicine · doi:10.1038/nm0597-558 · Cited by 591
Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J. C., Hodi, F. S., Liebster, L., Lam, P., Mentzer, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13141 · Cited by 571
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
Rosenberg, S. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80028-x · Cited by 566
Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys
Kawai, T., Cosimi, A. B., Colvin, R. B., Powelson, J., Eason, J., Kozlowski, T., Sykes, M., Monroy, R., Tanaka, M., & Sachs, D. H. (1995) · Transplantation · doi:10.1097/00007890-199501000-00018 · Cited by 549
Self-citationTimmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B., Okada, C. Y., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1517 · Cited by 545
Paglia, P., Chiodoni, C., Rodolfo, M., & Colombo, M. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.317 · Cited by 542
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., & Engleman, E. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141226398 · Cited by 541
Kwak, L. W., Campbell, M. J., Czerwinski, D. K., Hart, S., Miller, R. A., & Levy, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210223271705 · Cited by 533
Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question
Suchin, E. J., Langmuir, P. B., Palmer, E., Sayegh, M. H., Wells, A. D., & Turka, L. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.973 · Cited by 517
CD4 T Cells and Their Role in Antitumor Immune Responses
Toes, R. E. M., Ossendorp, F., Offringa, R., & Melief, C. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.753 · Cited by 508
Kottaridis, P. D., Milligan, D. W., Chopra, R., Chakraverty, R. K., Chakrabarti, S., Robinson, S., Peggs, K., Verfuerth, S., Pettengell, R., Marsh, J. C. W., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2419 · Cited by 504
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Vermorken, J. B., Claessen, A. M., van Tinteren, H., Gall, H. E., Ezinga, R., Meijer, S., Scheper, R. J., Meijer, C. J., Bloemena, E., Ransom, J. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07186-4 · Cited by 504
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
Schumacher, K., Haensch, W., Röefzaad, C., & Schlag, P. M. (2001) · PubMed · Cited by 503
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., & Zinkernagel, R. M. (2001) · Nature · doi:10.1038/35082583 · Cited by 493
O'Donnell, P. V., Luznik, L., Jones, R. J., Vogelsang, G. B., Leffell, M. S., Phelps, M., Rhubart, P., Cowan, K., Piantadosi, S., & Fuchs, E. J. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12171484 · Cited by 491
Diehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I. H., Schumacher, T. N. M., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (1999) · Nature Medicine · doi:10.1038/10495 · Cited by 469
Immune surveillance against a solid tumor fails because of immunological ignorance
Ochsenbein, A. F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H., & Zinkernagel, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2233 · Cited by 453
Löffler, A., Kufer, P., Lutterbüse, R., Zettl, F., Daniel, P. T., Schwenkenbecher, J. M., Riethmüller, G., Dörken, B., & Bargou, R. C. (2000) · Blood · doi:10.1182/blood.v95.6.2098 · Cited by 445
Brocker, T., Riedinger, M., & Karjalainen, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.541 · Cited by 442
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
Guinan, E. C., Boussiotis, V. A., Neuberg, D., Brennan, L. L., Hirano, N., Nadler, L. M., & Gribben, J. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402202 · Cited by 429
Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
Yee, C., Thompson, J. A., Roche, P., Byrd, D. R., Lee, P. P., Piepkorn, M., Kenyon, K., Davis, M. M., Riddell, S. R., & Greenberg, P. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1637 · Cited by 428
Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413497 · Cited by 426
Hurwitz, A. A., Foster, B. A., Kwon, E. D., Truong, T. N., Choi, E. M., Greenberg, N. M., Burg, M. B., & Allison, J. P. (2000) · PubMed · Cited by 425
Yee, C., Savage, P. A., Lee, P. P., Davis, M. M., & Greenberg, P. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2227 · Cited by 415
Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1
Gao, L., Bellantuono, I., Elsässer, A., Marley, S. B., Gordon, M. Y., Goldman, J. M., & Stauss, H. J. (2000) · Blood · doi:10.1182/blood.v95.7.2198 · Cited by 408
Marijt, W. A. E., Heemskerk, M. H. M., Kloosterboer, F. M., Goulmy, E., Kester, M. G. D., van der Hoorn, M. A. W. G., van Luxemburg-Heys, S. A. P., Hoogeboom, M., Mutis, T., Drijfhout, J. W., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530192100 · Cited by 408
Sotomayor, E. M., Borrello, I., Tubb, E., Rattis, F.-M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., & Levitsky, H. I. (1999) · Nature Medicine · doi:10.1038/10503 · Cited by 407
Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
Albert, M. L., Jegathesan, M., & Darnell, R. B. (2001) · Nature Immunology · doi:10.1038/ni722 · Cited by 402
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
Jäger, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jäger, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4760 · Cited by 398
Brocker, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1223 · Cited by 389
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke, J. H., Zea, A. H., Stanley, J., Longo, D., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O’Shea, J. J., Kudoh, S., & Klein, E. A. (1993) · PubMed · Cited by 379
Song, W., Kong, H.-L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M. A. S., & Crystal, R. G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1247 · Cited by 379
Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance
Ramsdell, F., & Fowlkes, B. J. (1990) · Science · doi:10.1126/science.1972593 · Cited by 366
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
Stanislawski, T., Voss, R.-H., Lotz, C., Sadovnikova, E., Willemsen, R. A., Kuball, J., Ruppert, T., Bolhuis, R. L. H., Melief, C. J., Huber, C., et al. (2001) · Nature Immunology · doi:10.1038/ni1001-962 · Cited by 362
Dudley, M. E., Wunderlich, J., Nishimura, M. I., Yu, D., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Sherry, R., et al. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200107000-00012 · Cited by 361
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R. M., Marincola, F. M., Leitman, S. F., Seipp, C. A., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00007 · Cited by 357
Schultze, J. L., Michalak, S., Seamon, M. J., Dranoff, G., Jung, K., Daley, J., Delgado, J. C., Gribben, J. G., & Nadler, L. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119822 · Cited by 355
Mackensen, A., Herbst, B., Chen, J.-L., K�hler, G., Noppen, C., Herr, W., Spagnoli, G. C., Cerundolo, V., & Lindemann, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t · Cited by 345
Bekkum, D. W. V., Roodenburg, J., Heidt, P. J., & Waaij, D. V. D. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.401 · Cited by 330
Serological identification of human tumor antigens
Sahin, U., Türeci, Ö., & Pfreundschuh, M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80053-2 · Cited by 315
Slansky, J. E., Rattis, F. M., Boyd, L. F., Fahmy, T., Jaffee, E. M., Schneck, J. P., Margulies, D. H., & Pardoll, D. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00052-2 · Cited by 309
Targeting p53 as a general tumor antigen.
Theobald, M., Biggs, J., Dittmer, D., Levine, A. J., & Sherman, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.11993 · Cited by 304
Dickinson, A. M., Wang, X.-N., Sviland, L., Vyth-Dreese, F. A., Jackson, G. H., Schumacher, T. N. M., Haanen, J. B. A. G., Mutis, T., & Goulmy, E. (2002) · Nature Medicine · doi:10.1038/nm0402-410 · Cited by 303
Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
Wang, R.-F., Wang, X., Atwood, A. C., Topalian, S. L., & Rosenberg, S. A. (1999) · Science · doi:10.1126/science.284.5418.1351 · Cited by 300
Salgia, R., Lynch, T., Skarin, A., Lucca, J., Lynch, C., Jung, K., Hodi, F. S., Jaklitsch, M., Mentzer, S., Swanson, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.091 · Cited by 296
Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A., & Hwu, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1213 · Cited by 294
Lokhorst, H. M., Schattenberg, A. V. M. B., Cornelissen, J. J., Thomas, L. L. M., & Verdonck, L. F. (1997) · Blood · doi:10.1182/blood.v90.10.4206 · Cited by 291
Harris, J. E., Ryan, L., Hoover, H. C., Stuart, R. K., Oken, M. M., Benson, A. B., Mansour, E., Haller, D. G., Manola, J., & Hanna, M. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.148 · Cited by 273
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Wang, R.-F. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01896-8 · Cited by 266
Mutis, T., Gillespie, G., Schrama, E., Falkenburg, J. H. F., Moss, P., & Goulmy, E. (1999) · Nature Medicine · doi:10.1038/10563 · Cited by 264
Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X. F., Shimizu, J., Fujiwara, H., & Hamaoka, T. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.3.1077 · Cited by 259
Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes
Theobald, M., Biggs, J., Hernández, J., Lustgarten, J., Labadie, C., & Sherman, L. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.833 · Cited by 256
Ludewig, B., Ochsenbein, A. F., Odermatt, B., Paulin, D., Hengartner, H., & Zinkernagel, R. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.795 · Cited by 252
Spitzer, T. R., McAfee, S., Sackstein, R., Colby, C., Toh, H. C., Multani, P., Saidman, S., Weymouth, D., Preffer, F., Poliquin, C., et al. (2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70056-5 · Cited by 247
Self-citationNakashima, M., Sonoda, K., & Watanabe, T. (1999) · Nature Medicine · doi:10.1038/11383 · Cited by 244
Morgan, D. J., Kreuwel, H. T. C., Fleck, S., Levitsky, H. I., Pardoll, D. M., & Sherman, L. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.643 · Cited by 244
Mapara, M. Y., Kim, Y.-M., Wang, S.-P., Bronson, R., Sachs, D. H., & Sykes, M. (2002) · Blood · doi:10.1182/blood-2002-01-0023 · Cited by 236
Self-citationChen, Q., Daniel, V., Maher, D. W., & Hersey, P. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560524 · Cited by 234
Slingluff, C. L., Yamshchikov, G. V., Neese, P. Y., Galavotti, H., Eastham, S., Engelhard, V. H., Kittlesen, D. J., Deacon, D. H., Hibbitts, S., Grosh, W. W., et al. (2001) · PubMed · Cited by 229
Jäger, E., Jäger, D., Karbach, J., Chen, Y.-T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L. J., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.625 · Cited by 229
Jäger, E., Stockert, E., Zidianakis, Z., Chen, Y.-T., Karbach, J., Jäger, D., Arand, M., Ritter, G., Old, L. J., & Knuth, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<506::aid-ijc10>3.0.co;2-6 · Cited by 227
Kwon, E. D., Foster, B. A., Hurwitz, A. A., Madias, C., Allison, J. P., Greenberg, N. M., & Burg, M. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15074 · Cited by 222
van Mierlo, G. J. D., den Boer, A. T., Medema, J. P., van der Voort, E. I. H., Fransen, M. F., Offringa, R., Melief, C. J. M., & Toes, R. E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107699 · Cited by 222
Maxwell, J. R., Weinberg, A., Prell, R. A., & Vella, A. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.107 · Cited by 219
André-Schmutz, I., Le Deist, F., Hacein-Bey-Abina, S., Vitetta, E., Schindler, J., Chedeville, G., Vilmer, E., Fischer, A., & Cavazzana-Calvo, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09413-8 · Cited by 219
Marks, D. I. (2002) · Blood · doi:10.1182/blood-2002-02-0506 · Cited by 216
Gastman, B., Atarshi, Y., Reichert, T. E., Saito, T., Balkir, L., Rabinowich, H., & Whiteside, T. L. (1999) · PubMed · Cited by 216
Sotomayor, E. M., Borrello, I., Rattis, F.-M., Cuenca, A. G., Abrams, J., Staveley-O'Carroll, K., & Levitsky, H. I. (2001) · Blood · doi:10.1182/blood.v98.4.1070 · Cited by 212
Molldrem, J. J., Lee, P. P., Kant, S., Wieder, E., Jiang, W., Lu, S., Wang, C., & Davis, M. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16398 · Cited by 209
Schultze, J. L., Cardoso, A. A., Freeman, G. J., Seamon, M. J., Daley, J., Pinkus, G. S., Gribben, J. G., & Nadler, L. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8200 · Cited by 206
Promiscuous gene expression and central T-cell tolerance: more than meets the eye
Kyewski, B., Derbinski, J., Gotter, J., & Klein, L. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02248-2 · Cited by 199
Rooke, R., Waltzinger, C., Benoist, C., & Mathis, D. (1997) · Immunity · doi:10.1016/s1074-7613(00)80515-4 · Cited by 196
von Bergwelt-Baildon, M. S., Vonderheide, R. H., Maecker, B., Hirano, N., Anderson, K. S., Butler, M. O., Xia, Z., Zeng, W. Y., Wucherpfennig, K. W., Nadler, L. M., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3319 · Cited by 192
Immunity against cancer: lessons learned from melanoma
Houghton, A. N., Gold, J. S., & Blachere, N. E. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00195-3 · Cited by 190
Marrogi, A. J., Munshi, A., Merogi, A. J., Ohadike, Y., El-Habashi, A., Marrogi, O. L., & Freeman, S. M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971021)74:5<492::aid-ijc3>3.0.co;2-z · Cited by 183
Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman, J. M., Singh, G., Hermanson, G., Hobart, P. M., Czerwinski, D. K., Taidi, B., Rajapaksa, R., Caspar, C. B., van Beckhoven, A., & Levy, R. (2002) · PubMed · Cited by 179
Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D.-C., & Perreault, C. (2001) · Nature Medicine · doi:10.1038/89907 · Cited by 178
Chiodoni, C., Paglia, P., Stoppacciaro, A., Rodolfo, M., Parenza, M., & Colombo, M. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.125 · Cited by 175
Pelot, M. R., Pearson, D. A., Swenson, K., Zhao, G., Sachs, J., Yang, Y.-G., & Sykes, M. (1999) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.1999.v5.pm10392959 · Cited by 171
Self-citationKlein, L., Klein, T., Rüther, U., & Kyewski, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.5 · Cited by 165
Carcinoembryonic Antigen as a Target for Therapeutic Anticancer Vaccines: A Review
Berinstein, N. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.017 · Cited by 158
Klein, C., Büeler, H., & Mulligan, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1699 · Cited by 156
Mathas, S., Rickers, A., Bommert, K., Dörken, B., & Mapara, M. Y. (2000) · PubMed · Cited by 155
Self-citationRole of Bacterial Microflora in Development of Intestinal Lesions From Graft-Versus-Host Reaction
van Bekkum, D. W., & Knaan, S. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/58.3.787 · Cited by 147
Beelen, D., Haralambie, E., Brandt, H., Linzenmeier, G., Muller, K., Quabeck, K., Sayer, H., Graeven, U., Mahmoud, H., & Schaefer, U. (1992) · Blood · doi:10.1182/blood.v80.10.2668.2668 · Cited by 143
Liso, A., Stockerl-Goldstein, K. E., Auffermann-Gretzinger, S., Benike, C. J., Reichardt, V. L., van Beckhoven, A., Rajapaksa, R., Engleman, E. G., Blume, K. G., & Levy, R. (2000) · Transplantation and Cellular Therapy · doi:10.1016/s1083-8791(00)70027-9 · Cited by 142
Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
Huang, A. Y.-C., Bruce, A. T., Pardoll, D. M., & Levitsky, H. I. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.769 · Cited by 140
Kim, Y., Sachs, T. E., Asavaroengchai, W., Bronson, R. T., & Sykes, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16950 · Cited by 135
Self-citationGong, J., Koido, S., Chen, D., Tanaka, Y., Huang, L. H., Avigan, D., Anderson, K. C., Ohno, T., & Kufe, D. W. (2002) · Blood · doi:10.1182/blood.v99.7.2512 · Cited by 129
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge, T. H., Hoover, S. K., Süßkind, B., Barrett, S. K., & Bear, H. D. (1992) · PubMed · Cited by 127
Kawakami, Y., Dang, N., Wang, X., Tupesis, J. P., Robbins, P. F., Wang, R., Wunderlich, J. R., Yannelli, J. R., & Rosenberg, S. A. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200001000-00004 · Cited by 124
De novo tumors after liver transplantation: A single-institution experience
Sanchez, E. Q., Marubashi, S., Jung, G., Levy, M. F., Goldstein, R. M., Molmenti, E. P., Fasola, C. G., Gonwa, T. A., Jennings, L. W., Brooks, B. K., et al. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.29350 · Cited by 123
Tumor expression of Fas ligand (CD95L) and the consequences
Walker, P. R., Saas, P., & Dietrich, P. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80225-2 · Cited by 121
The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity
Clarke, S. R. M. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.607 · Cited by 115
Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.
Höglund, P., Ljunggren, H., Öhlén, C., Ahrlund-Richter, L., Scangos, G. A., Bieberich, C. J., Jay, G. D., Klein, G., & Kärre, K. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.4.1469 · Cited by 111
Stutman, O. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.2.353 · Cited by 106
McAneny, D. B., Ryan, C. A., Beazley, R. M., & Kaufman, H. L. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305769 · Cited by 104
Ox40 Costimulation Enhances the Development of T Cell Responses Induced by Dendritic Cells In Vivo
Smedt, T. D., Smith, J., Baum, P. R., Fanslow, W. C., Butz, E. A., & Maliszewski, C. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.661 · Cited by 95
Cochlovius, B., Kipriyanov, S. M., Stassar, M. J. J. G., Schuhmacher, J., Benner, A., Moldenhauer, G., & Little, M. (2000) · PubMed · Cited by 91
Rubio, M., Kim, Y., Sachs, T. E., Mapara, M. Y., Zhao, G., & Sykes, M. (2003) · Blood · doi:10.1182/blood-2002-12-3949 · Cited by 85
Self-citationCayeux, S., Beck, C., Aicher, A., Dörken, B., & Blankenstein, T. J. F. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250831 · Cited by 80
Cooke, K. R., Hill, G. R., Gerbitz, A., Kobzik, L., Martin, T. R., Crawford, J. M., Brewer, J. P., & Ferrara, J. L. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6612 · Cited by 78
The role of CD40 in peripheral T cell tolerance and immunity
Diehl, L., den Boer, A. T., van der Voort, E. I. H., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000126 · Cited by 78
Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions
Blazar, B. R., Lees, C. J., Martin, P. J., Noelle, R. J., Kwon, B. S., Murphy, W. J., & Taylor, P. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4901 · Cited by 73
Benlalam, H., Labarrière, N., Linard, B., Derré, L., Diez, E., Pandolfino, M., Bonneville, M., & Jotereau, F. (2001) · European Journal of Immunology · Cited by 72
Marmé, A., Strauß, G., Bastert, G., Grischke, E., & Moldenhauer, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10562 · Cited by 58
Daniel, P. T., Kroidl, A., Kopp, J., Sturm, I., Moldenhauer, G., Dörken, B., & Pezzutto, A. (1998) · Blood · doi:10.1182/blood.v92.12.4750 · Cited by 56
Antigen presentation in retroviral vector-mediated gene transfer in vivo
Song, E. S., Lee, V., Surh, C. D., Lynn, A., Brumm, D., Jolly, D. J., Warner, J. F., & Chada, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1943 · Cited by 50
Rohrer, J. W., Barsoum, A. L., Dyess, D. L., Tucker, J. A., & Coggin, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6880 · Cited by 36
Spontaneous Tumors in Nude Mice: Effect of the Viable Yellow Gene
Stutman, O. (2008) · Experimental Cell Biology · doi:10.1159/000162929 · Cited by 30
DNA fusion vaccines against B-cell tumors
Zhu, D., Rice, J., Savelyeva, N., & Stevenson, F. K. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02126-8 · Cited by 30
Sykes, M. (2003) · doi:10.1002/9780470987070.ch24 · Cited by 11
Self-citation
Cited by
Consensus statement on the pathology of IgG4-related disease
Deshpande, V., Zen, Y., Chan, J. K., Yi, E. E., Sato, Y., Yoshino, T., Klöppel, G., Heathcote, J. G., Khosroshahi, A., Ferry, J. A., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.72 · Cited by 2,596
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966
“The tumor microenvironment and local cytokine milieu are often suppressive toward immune function and can actively induce immune cell anergy or death (5, 6).”
BackgroundHiraoka, N., Onozato, K., Kosuge, T., & Hirohashi, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0369 · Cited by 831
Mesenchymal stem cells avoid allogeneic rejection
Ryan, J. M., Barry, F. P., Murphy, J. M., & Mahon, B. P. (2005) · Journal of Inflammation · doi:10.1186/1476-9255-2-8 · Cited by 714
The therapeutic promise of the cancer stem cell concept
Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 636
Metadata
- Authors
- Mapara, M. Y., & Sykes, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-03-15
- Volume
- 22
- Issue
- 6
- Pages
- 1136-1151
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2131774025
- Cited by
- 325
- References
- 175
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.